<p>Airway resistance (panel A) and dynamic compliance (panel B) in challenged only wild-type (IL-22<sup>+/+</sup> chall, n = 12), challenged only IL-22 deficient (IL-22<sup>−/−</sup> chall, n = 12), sensitized and challenged wild-type (IL-22<sup>+/+</sup> sens/chall, n = 13) and sensitized and challenged IL-22 deficient (IL-22<sup>−/−</sup> sens/chall, n = 13) mice. Results are expressed as mean±SEM from 2 independent experiments. # p<0.01, *p<0.05. Panel C shows differential cell counts for eosinophils in BAL fluid. Each dot represents a single mouse, bar represents mean. # p<0.05 compared to IL-22<sup>+/+</sup> chall and IL-22<sup>−/−</sup> chall; * p<0.05 compared to all other groups. N.D.: not detectable. Panel D: Tissue inflammation wa...
<p>C57BL/6 mice (black bars) and IL-22<sup>−/−</sup> (white bars) mice were infected with approx. 10...
Rationale: IL-22 has both proinflammatory and antiinflammatory properties. Its role in allergic lung...
<p>Mice were sensitized EC with OVA three times and then treated intranasally with OVA or PBS for 3 ...
<p>Airway responsiveness (panel A), cell counts in BAL fluid (panel B) and lung tissue inflammation ...
<p>Panel A: Expression of IL-22 and IL-22 R1 (IL-22 Rc) was assessed in lung tissue of challenged on...
Interleukin (IL)-22 is an effector cytokine, which acts primarily on epithelial cells in the skin, g...
Interleukin (IL)-22 is an effector cytokine, which acts primarily on epithelial cells in the skin, g...
<p>Panel A: IL-22 intracellular staining in lung cells 24 hrs after inhaled exposure of OT II mice w...
<p>(A) High levels of IL-22 cytokine were seen in the BAL of PBS and OVA-stimulated IL-22 Tg(+) mice...
<p>(A, B) Invasive PFT of OVA stimulated IL-22 Tg(+) and Tg(−) mice was assessed (FlexiVent, SciQues...
<p><b>A:</b> 16 female B6.129S7-ifng<sup>tm1Ts</sup> (B6.IFNγKO) mice were immunized with collagen a...
IL-22 is a Th17/Th22 cytokine that is increased in asthma. However, recent animal studies showed con...
<p>Mice were sensitized and challenged as described in Methods. Serum levels of immunoglobulins were...
<div><p>IL-22 is a Th17/Th22 cytokine that is increased in asthma. However, recent animal studies sh...
IL-22 is a Th17/Th22 cytokine that is increased in asthma. However, recent animal studies showed con...
<p>C57BL/6 mice (black bars) and IL-22<sup>−/−</sup> (white bars) mice were infected with approx. 10...
Rationale: IL-22 has both proinflammatory and antiinflammatory properties. Its role in allergic lung...
<p>Mice were sensitized EC with OVA three times and then treated intranasally with OVA or PBS for 3 ...
<p>Airway responsiveness (panel A), cell counts in BAL fluid (panel B) and lung tissue inflammation ...
<p>Panel A: Expression of IL-22 and IL-22 R1 (IL-22 Rc) was assessed in lung tissue of challenged on...
Interleukin (IL)-22 is an effector cytokine, which acts primarily on epithelial cells in the skin, g...
Interleukin (IL)-22 is an effector cytokine, which acts primarily on epithelial cells in the skin, g...
<p>Panel A: IL-22 intracellular staining in lung cells 24 hrs after inhaled exposure of OT II mice w...
<p>(A) High levels of IL-22 cytokine were seen in the BAL of PBS and OVA-stimulated IL-22 Tg(+) mice...
<p>(A, B) Invasive PFT of OVA stimulated IL-22 Tg(+) and Tg(−) mice was assessed (FlexiVent, SciQues...
<p><b>A:</b> 16 female B6.129S7-ifng<sup>tm1Ts</sup> (B6.IFNγKO) mice were immunized with collagen a...
IL-22 is a Th17/Th22 cytokine that is increased in asthma. However, recent animal studies showed con...
<p>Mice were sensitized and challenged as described in Methods. Serum levels of immunoglobulins were...
<div><p>IL-22 is a Th17/Th22 cytokine that is increased in asthma. However, recent animal studies sh...
IL-22 is a Th17/Th22 cytokine that is increased in asthma. However, recent animal studies showed con...
<p>C57BL/6 mice (black bars) and IL-22<sup>−/−</sup> (white bars) mice were infected with approx. 10...
Rationale: IL-22 has both proinflammatory and antiinflammatory properties. Its role in allergic lung...
<p>Mice were sensitized EC with OVA three times and then treated intranasally with OVA or PBS for 3 ...